Anakinra, is an IL-1 receptor antagonist which is used in RA, Still’s disease, cryopyrin-associated periodic syndrome (CAPS), and in patients with gout. This evidence concerns the gene NLRP3 and systemic-onset juvenile idiopathic arthritis.